S?ndrome metab?lico
作者： D. Snchez Fuentes , M. Budio Snchez
DOI: 10.1016/S0211-3449(08)75424-9
关键词: Medicine 、 Gynecology
摘要:
elsevier.com 
sci-hub.se 参考文章(54)
Apoor S. Gami, Brandi J. Witt, Daniel E. Howard, Patricia J. Erwin, Lisa A. Gami, Virend K. Somers, Victor M. Montori, Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death Journal of the American College of Cardiology. ,vol. 49, pp. 403- 414 ,(2007) , 10.1016/J.JACC.2006.09.032
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabetic Medicine. ,vol. 16, pp. 442- 443 ,(1999) , 10.1046/J.1464-5491.1999.00059.X
Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner, None, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet. ,vol. 365, pp. 1389- 1397 ,(2005) , 10.1016/S0140-6736(05)66374-X
M. P. Stern, K. Williams, C. Gonzalez-Villalpando, K. J. Hunt, S. M. Haffner, Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care. ,vol. 27, pp. 2676- 2681 ,(2004) , 10.2337/DIACARE.27.11.2676
Edwin A M Gale, Should we dump the metabolic syndrome?: Yes BMJ. ,vol. 336, pp. 640- 640 ,(2008) , 10.1136/BMJ.39477.500197.AD
F. Xavier Pi-Sunyer, Louis J. Aronne, Hassan M. Heshmati, Jeanne Devin, Julio Rosenstock, for the RIO-North America Study Group, Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients JAMA. ,vol. 295, pp. 761- 775 ,(2006) , 10.1001/JAMA.295.7.761
John B. Dixon, Paul E. O’Brien, Julie Playfair, Leon Chapman, Linda M. Schachter, Stewart Skinner, Joseph Proietto, Michael Bailey, Margaret Anderson, Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes JAMA. ,vol. 299, pp. 316- 323 ,(2008) , 10.1001/JAMA.299.3.316
Shubha Srinivasan, Geoffrey R. Ambler, Louise A. Baur, Sarah P. Garnett, Mirijana Tepsa, Fabian Yap, Glenn M. Ward, Christopher T. Cowell, Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 2074- 2080 ,(2006) , 10.1210/JC.2006-0241
A. Halpern, M. C. Mancini, H. Suplicy, M. T. Zanella, G. Repetto, J. Gross, M. Jadzinsky, J. Barranco, P. Aschner, L. Ramirez, A. G. Matos, Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients. Diabetes, Obesity and Metabolism. ,vol. 5, pp. 180- 188 ,(2003) , 10.1046/J.1463-1326.2003.00262.X
María Teresa Martínez-Larrad, Cristina Fernández-Pérez, José Luis González-Sánchez, Alicia López, Josefa Fernández-Álvarez, Jesús Riviriego, Manuel Serrano-Ríos, None, Prevalencia del síndrome metabólico (criterios del ATP-III). Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia Medicina Clinica. ,vol. 125, pp. 481- 486 ,(2005) , 10.1157/13080210